Skip to main content
OpenTrials
Completed

NCT Number: NCT02680470

Virtual Observed Therapy for Patients With Tuberculosis

Using modern technology, investigators will observe participants taking their TB tablets three times per week using a mobile phone, iPod or computer with camera facilities in the participants home environment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tuberculosis Actinomycetales Infections Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Infections Mycobacterium Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Royal Infirmary of Edinburgh

Edinburgh, EH16 4SA, United Kingdom

About this study

Using modern technology, the investigators will observe participants taking their TB tablets three times per week using a mobile phone, iPod or computer with camera facilities in the participants home environment.

Investigators will connect to the participants mobile phone, iPod or computer at a mutually convenient time three times per week who will observe participants taking their TB medication.

The Virtual Observed Therapy will be carried out using NHS Lothian approved software (mobile app called POLYCOM) three times per week. This is software similar to Skype but POLYCOM is the approved software we use in NHS Lothian.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any patient requiring Tuberculosis treatment

Exclusion criteria

Those refusing consent; the healthcare professional deems the patient that will not be able to comply with VOT

Treatment and study plan

Virtual observed therapy

Device

Virtual Observation of participants taking their medication

Primary outcomes

  1. Treatment completion rates using VOT compared with historical completion rates.

    Time frame: length of TB treatment (usually 6-12 months)

Secondary outcomes

  1. % Cure from TB treatment

    Time frame: length of TB treatment (usually 6-12 months)

  2. number of VOT actually observed divided by the expected VOT observed

    Time frame: length of TB treatment (usually 6-12 months)

  3. patient satisfaction questionnaire at end of treatment

    Time frame: length of TB treatment (usually 6-12 months)

  4. Mortality

    Time frame: length of TB treatment (usually 6-12 months)

Sponsors and collaborators

Lead sponsor

University of Edinburgh

Other

Collaborators

  • NHS Lothian

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Feb 11, 2016
Registry last updated
May 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.